Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
UPDATE: Aytu Biosciences (AYTU) PT Lowered to $5 at Cantor Fitzgerald, "Overweight" Rating Reiterated, Analyst Expects "Upwards Earnings Revisions Should Drive Shares Higher"
-
Cantor Fitzgerald Reiterates Aytu Biosciences (AYTU) at Overweight, $11 PT, Sees it as Positive Development Potentially Extending ADHD Franchise Revenue Runway
-
Aytu BioPharma to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
-
Cantor Fitzgerald Reiterates Overweight Rating on Aytu Biosciences (AYTU), Company's Transformation Remains Underappreciated
-
Aytu BioScience's (AYTU) Experienced CFO Hire is a Positive For the Company - Cantor Fitzgerald
-
Companies with NDRs 7/20
-
Pre-Open Stock Movers 03/30: (MBRX) (ABCL) (SEEL) Higher; (WVE) (BFLY) (CLDX) Lower (more...)
-
After-Hours Stock Movers 03/29: (BIOC) (SEAC) (NOVN) Higher; (WVE) (BFLY) (CLDX) Lower (more...)
-
Cantor Fitzgerald Starts Aytu Biosciences (AYTU) at Overweight
